Impacts of Yiqi Huoxue Decoction on Cardiac Function and Life Quality in Patients with Qi-deficiency and Blood Stasis Syndrome in Chronic Heart Failure
|更新时间:2024-01-04
|
Impacts of Yiqi Huoxue Decoction on Cardiac Function and Life Quality in Patients with Qi-deficiency and Blood Stasis Syndrome in Chronic Heart Failure
Chinese Journal of Experimental Traditional Medical FormulaeVol. 21, Issue 19, Pages: 162-166(2015)
ZHANG Ming-li, JIANG Rui-xue. Impacts of Yiqi Huoxue Decoction on Cardiac Function and Life Quality in Patients with Qi-deficiency and Blood Stasis Syndrome in Chronic Heart Failure[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(19): 162-166.
DOI:
ZHANG Ming-li, JIANG Rui-xue. Impacts of Yiqi Huoxue Decoction on Cardiac Function and Life Quality in Patients with Qi-deficiency and Blood Stasis Syndrome in Chronic Heart Failure[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(19): 162-166. DOI: 10.13422/j.cnki.syfjx.2015190162.
Impacts of Yiqi Huoxue Decoction on Cardiac Function and Life Quality in Patients with Qi-deficiency and Blood Stasis Syndrome in Chronic Heart Failure
Objective: To observe the therapeutic efficacy of Yiqi Huoxue decoction on cardiac function and life quality in patients with qi-deficiency and blood stasis syndrome in chronic heart failure (CHF)
as well as its impact on cystatin C (Cys C)
homocysteine(Hcy)
and cyclophilin A(Cyp A) in serum. Method: One hundred and eighteen patients with CHF (Qi deficiency and blood stasis syndrome) were randomly assigned to either control group or observation group of 59 patients each according to random number table. Two groups were treated according to the guide of the diagnosis and treatment of chronic heart and failure. Patients of control group accepted hydrochlorothiazide tablet (25 mg/time
qd)
captopril (12.5 mg and bid)
digoxin tablet (0.25 mg and qd)
and Metoprolol(25 mg
bid).The patients of observation group were treated with additional Yiqi Huoxue decoction based on control treatment
1 dose/d and bid. Treatment course was 4 weeks in both groups. Lee's CHF score
NYHA cardiac heart grading
6 minutes walk test (6 MWT)
and clinical symptom score were compared between both groups before and after treatment. The quality of life of the two groups was evaluated by the minnesota heart failure life quality questionnaire. Left ventricular ejection fraction (LVEF) and E/A were detected using color Doppler ultrasound diagnostic system.Cys C
Hcy and Cyp A were tested in both groups. Result: Total effective rate for observation group was 93.22%
higher than 79.66% in control group (P<0.05). After treatment
6 MWT in observation group was higher than that of control group
while scores of life quality and Chinese medicine(TCM) syndrome were obviously lower than those of control group
with significant differences between two groups (P<0.05). After treatment
LVEF and E/A were obviously increased in both group (P<0.01)
and the increase value in observation group was higher than that in control group (P<0.05). After treatment
Cys C
Hcy
and Cyp A in observation group was remarkably lower than those in control group (P<0.05). Conclusion: Additional Yiqi Huoxue decoction based on the cardiotonic and diuretic therapy can improve cardiac function and life quality for CHF patients with heart qi deficiency and blood stasis
and its mechanism may be related to depressing Cys C